Rasagiline for dysexecutive symptoms during wearing-off in Parkinson’s disease: a pilot study
- 27 September 2017
- journal article
- research article
- Published by Springer Nature in Neurological Sciences
- Vol. 39 (1) , 141-143
Abstract
Wearing-off refers to the predictable worsening of motor and sometimes non-motor symptoms of Parkinson’s disease occurring at the end of levodopa dose that improves with the next drug dose. Here, we investigated the efficacy of rasagiline on executive functions at the end of levodopa dose in patients displaying symptoms of wearing-off. Rasagiline was well-tolerated and produced a significant improvement at the Frontal Assessment Battery, together with improvement of motor symptoms at the end of levodopa dose. These results suggest that treatment of motor symptoms of wearing-off with rasagiline may be accompanied by improvement of executive functions, and further support the need for optimizing dopamine replacement therapy in fluctuating Parkinson’s disease patients.Keywords
This publication has 8 references indexed in Scilit:
- Rasagiline for the treatment of Parkinson’s disease: an updateExpert Opinion on Pharmacotherapy, 2015
- The early course of affective and cognitive symptoms in de novo patients with Parkinson’s diseaseJournal of Neurology, 2014
- Frontal assessment battery scores and non-motor symptoms in parkinsonian disordersNeurological Sciences, 2011
- The effect of dopamine therapy on ventral and dorsal striatum-mediated cognition in Parkinson’s disease: support from functional MRIBrain, 2011
- The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: A randomized, double‐blind, placebo‐controlled, multicenter studyMovement Disorders, 2011
- Levodopa-related wearing-off in Parkinson's disease: identification and managementCurrent Medical Research and Opinion, 2009
- The sensitivity and specificity of the 9-item Wearing-off QuestionnaireParkinsonism & Related Disorders, 2008
- Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task forceMovement Disorders, 2007